Gut Microbiome Focused EnteroBiotix Receives $2.5 Million Seed Investment

EnteroBiotix, a leading clinical stage microbiome therapeutics company headquartered in Aberdeen, Scotland, has closed an oversubscribed seed extension investment and is set for international expansion following the opening of a new office in Boston, US.